[1]
H. Gilzad-Kohan and F. Jamali, “Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2 ”, J Pharm Pharm Sci, vol. 23, no. 1, pp. 259–277, Jul. 2020.